Correlation Between DV Biomed and Handa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both DV Biomed and Handa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DV Biomed and Handa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DV Biomed Co and Handa Pharmaceuticals, you can compare the effects of market volatilities on DV Biomed and Handa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DV Biomed with a short position of Handa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of DV Biomed and Handa Pharmaceuticals.

Diversification Opportunities for DV Biomed and Handa Pharmaceuticals

-0.31

Correlation Coefficient

DV Biomed  Handa Pharmaceuticals

Very good diversification

The 3 months correlation between 6539 and Handa is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding DV Biomed Co and Handa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Handa Pharmaceuticals and DV Biomed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DV Biomed Co are associated (or correlated) with Handa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Handa Pharmaceuticals has no effect on the direction of DV Biomed i.e., DV Biomed and Handa Pharmaceuticals go up and down completely randomly.

Pair Corralation between DV Biomed and Handa Pharmaceuticals

Assuming the 90 days trading horizon DV Biomed Co is expected to generate 1.09 times more return on investment than Handa Pharmaceuticals. However, DV Biomed is 1.09 times more volatile than Handa Pharmaceuticals. It trades about -0.06 of its potential returns per unit of risk. Handa Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest  12,476  in DV Biomed Co on October 12, 2024 and sell it today you would lose (6,576) from holding DV Biomed Co or give up 52.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

DV Biomed Co  vs.  Handa Pharmaceuticals

DV Biomed

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DV Biomed Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Handa Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Handa Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Handa Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with DV Biomed and Handa Pharmaceuticals

The main advantage of trading using opposite DV Biomed and Handa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DV Biomed position performs unexpectedly, Handa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Handa Pharmaceuticals will offset losses from the drop in Handa Pharmaceuticals' long position.

The idea behind DV Biomed Co and Handa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.